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The past decade saw substantial growth in radiotherapy-related research within the United Kingdom 
(UK).(1) This welcome increase in activity has been accompanied by considerable development of the 
UK radiation oncology and radiobiology research landscape. One major example is the establishment 
in 2019 of a Cancer Research UK (CRUK) Radiotherapy Research Network.(2) The success of initiatives 
such as this and the continued expansion of the UK radiotherapy research effort are predicated on the 
availability of an appropriately skilled workforce. However, in recent years the number of clinical 
oncology consultants who hold research posts has fallen.(3) 
 
In parallel, a frequently occurring theme identified by surveys of registrars and newly appointed 
consultants is one of fledgling clinical oncologists feeling underprepared to participate in and lead 
research.(4-8) This was most recently emphasised by the Royal College of Radiologists (RCR) Oncology 
Registrars Forum annual survey, which in 2018 reported that half of those responding felt that they 
would benefit from greater research activity.(8) As highlighted by Faivre-Finn, a glass ceiling also 
undoubtedly persists for women pursuing a career in academic clinical oncology.(9) 
 
Whilst not unique to the UK,(10-12) these challenges emphasise the need to develop a training 
environment in which all clinical oncologists are enthused and enabled to participate in research. As 
we reflect here, this will depend not just on providing every trainee with exposure to research or with 
the space and time to undertake it; but on doing so from the earliest stages of training within an 
environment rich in incentives, support and mentorship. A roadmap summarising these strategies is 
provided in Fig. 1.  
 
SEEING IS BELIEVING 
A first step in ensuring the continued growth of academic clinical oncology in the UK is to ensure both 
that fledgling academics are attracted to the specialty, and that all clinical oncologists in training are 
provided with research experience and education. In facilitating academic literacy, such early research 
exposure confers a number of additional benefits, including improved trainee satisfaction and interest 
in academia.(13-17) It may also serve to enhance adherence to evidence-based practice, trainee 
engagement with which is reported to be low in the UK.(18)  
 
Attracting the brightest talent 
A majority of doctors receive only very limited exposure to clinical oncology until well into their 
postgraduate training.(19) As a consequence, medical students and early postgraduate trainees with 
an interest in and aptitude for academia may look to other specialties for early academic 
opportunities. Equally, those who are interested in cancer may choose to pursue medical oncology 
instead of clinical oncology due to the historical reputation of the former as the more academic 
specialty. Given that medical oncologists hold an average of 1.96 academic PAs compared with 0.1 
PAs for clinical oncologists, this perception is perhaps not unsurprising.(3,20) 
 
It is therefore important that strategies to recruit fledgling clinical researchers focus on enhancing the 
visibility of academic clinical oncology. In order to compete with other medical specialties, these 
efforts should be targeted towards medical students as well as trainees. To this end, the RCR Summer 
Undergraduate Research Fellowship (SURF) scheme, which supports medical students to undertake 
an eight week period of research in clinical oncology, is to be welcomed.(21) Parallel approaches to 
support and incentivise pre-specialty trainee doctors such as Academic Foundation Programme (AFP) 
trainees to undertake projects related to clinical oncology should also be considered. These need not 
be substantial financial awards. Instead, if appropriately badged and competitively awarded, small 
pre-doctoral scholarships specific to radiation oncology could serve to attract motivated trainees to, 
and in turn incentivise them to consider a career in, academic clinical oncology.   
 
Paired with appropriate mentorship and targeted career support, these steps would in theory 
generate a base from which promising clinical academics could be recruited. For most, National 
Institute for Health Research (NIHR) Academic Clinical Fellowship (ACF) posts or their equivalents 
provide an ideal route of entry into academic clinical oncology. However, between 2007-2017 there 
were a maximum of 45 such ACFs available across 11 centres (E Brown, personal communication, 
2018); 34 of which offered entry at Specialty Training (ST) 3 level or above, risking the attrition of 
junior academics to other ‘core’ medical specialties offering posts starting at ST1. Many of these ACFs 
were offered in competition with other specialties, including medical oncology, and as such there were 
likely far fewer than 45 clinical oncology ACFs appointed over this period. Focus should therefore be 
applied to increasing the number and geographical spread of these posts (through increasing 
competitive applications to NIHR for clinical oncology ACF posts), and to either enabling ST1 entry or 
to providing clinical oncology-focussed research opportunities and training for core medical trainees 
who have undertaken an AFP but are not yet ready to progress to an ST3-entry ACF.  
 
Immersing trainees in research 
Approaches to ensure that all trainees are immersed in research once appointed to clinical oncology 
should also be considered. Enabling this universal academic exposure would serve to upskill the 
specialty whilst additionally providing an opportunity to spark academic interest amongst those not 
already pursuing integrated academic training (IAT). However, the radiation oncology research 
landscape is broad, encompassing areas as diverse as technical radiotherapy, basic laboratory work, 
health services research and clinical trials (Fig. 2). In light of this, it may be difficult for trainees naïve 
to the full breadth of the specialty to find or develop an area of research that matches their interests 
and expertise. Geographical variation in clinical oncology research activity may further exacerbate this 
challenge. In a recent exercise, CTRad identified only seven centres as demonstrating emerging or 
current research excellence, with a similar number contributing to CRUK RadNet.(2,22) Just two of 
these centres, in Manchester and London, house NHS proton beam therapy (PBT), whilst other new 
technologies such as MR-Linac are similarly concentrated.(23) There is no doubt that high quality 
research occurs outside of these foci, but such a concentration of expertise and equipment may cause 
disparities in the academic opportunities available to trainees across the country. Reflecting these 
concerns, last year clinical oncology ACFs were concentrated in just six centres. 
 
One route through which early exposure to research may be gained by trainees regardless of their 
location is through participation in multi-centre trainee-led research projects. Established in 2017, The 
National Oncology Trainees Collaborative for Healthcare Research (NOTCH) oversees a number of 
these and provides opportunities for trainees to gain experience participating in, proposing and 
leading research studies.(24) Trainees may also gain experience by participating in the RCR-endorsed 
NIHR Associate Principal Investigator (PI) scheme, though opportunities to capitalise on this 
programme may again vary by centre.(25) 
 
It is of equal importance that higher-level research opportunities, including those related to novel 
technologies, are made available to trainees regardless of their level of clinical training or their 
location. Publicising existing opportunities, including through the RCR Trainee Research Network and 
webpages, social media and via webinars, is a simple but essential first step towards realising this goal. 
However, training and research stakeholders should also lend considerable focus to enabling trainees 
to capitalise on research opportunities outside of their region, or even outside of the UK. The provision 
of financial support is an important consideration in this regard but logistical and administrative 
support to cater for an individual’s personal circumstances, including facilitating distance or working 
between two regions, is likely to be as beneficial.  
 
Finding the time & space to grow 
For the initiatives outlined thus far to equitably succeed, it is important that the clinical oncology 
curriculum provides dedicated time and incentives for trainees to pursue them. As a craft specialty in 
which trainees are already required to complete a number of postgraduate examinations whilst 
gaining competencies in acute oncology, the use of systemic anti-cancer therapies and the delivery of 
radiotherapy, necessitating additional research proficiency may be challenging. However, in the 
absence of embedded research time, academic opportunities may preferentially fall to those able to 
pursue them outside of normal working hours; an adverse impact of which may be an undesired 
strengthening of the glass ceiling faced by women in academic clinical oncology. Equally, trainees 
require not just dedicated time for research, but a supportive training environment in which to 
undertake it. The importance of Training Programme Directors (TPDs) in establishing this cannot be 
overstated. On this basis, an ‘Academic Training Champion’ should be considered as a means to 
support TPDs to facilitate research training. 
 
For those pursuing higher research training, the requirement to gain an array of clinical competencies 
alongside considerable research experience presents an additional challenge, as does deciding when 
to pursue an out-of-programme (OOP) period of research or a higher degree. Ideally, formal OOP 
activity should be undertaken with sufficient time remaining in clinical training to allow trainees to 
begin to transition towards research independence. However, for most this means striking a difficult 
balance between building a research career whilst achieving clinical oncology competencies and 
progressing through postgraduate examinations. It is clearly important that the same clinical 
milestones are achieved by all trainees, regardless of their academic intentions. However, 
considerable emphasis should be placed on competency rather than time-based progression to ensure 
both that training time is not unduly extended, and that academic work can be afforded equal priority.  
 
Knowledge is key 
Where possible, all trainees should have access to formal research teaching in order to contextualise 
the early and sustained academic exposure advocated here. This would ideally build on existing 
initiatives, including the statistics and trials training incorporated in the First FRCR programme, and 
the current requirement for clinical oncology registrars to hold Good Clinical Practice certification. At 
a local level, centres could be encouraged to deliver a wider programme incorporating formal training 
in research methods as well as supported journal club analyses of oncology research. Nationally, this 
could be supported with a series of webinars and by peer-training initiatives such as that planned by 
NOTCH; research and training stakeholder support for which is to be welcomed. Trainees may be 
incentivised to pursue both this research and the wider research experience we have advocated using 
schemes such as the research passport used in Australia and New Zealand.(26,27) 
  
Knowing where to turn 
Peer-peer and senior mentorship are crucial for supporting trainees to navigate the complex array of 
academic pathways outlined here, regardless of their degree of academic ambition.(28) A formal 
national programme to cultivate mentoring relationships would help reduce inter-centre variation and 
ensure that all trainees know where to turn for advice on how they might contribute to the growing 
UK radiotherapy research effort. 
 
At a higher level, it would also be beneficial for centres to support one another with respect to many 
of the initiatives outlined here. This might include through sharing best practice for securing IAT posts 
such as ACFs or Academic Clinical Lectureships, through outlining strategies to ensure research 
projects can be pitched towards more junior trainees or through generating projects that might be 
shared across centres with access to different resources. As has recently been outlined, support and 
guidance is also required for trainees who secure advanced post-doctoral funding, such as a Clinician 
Scientist award.(29) 
 
Inspiring the next generation 
The research achievements of the UK clinical oncology community are world-leading.(1,30) Beyond 
providing the opportunities, time and resources to pursue research training outlined here, the 
importance of inspiring the next generation of clinical oncologists to build on these strong foundations 
should not be understated. Whilst individual mentoring relationships are important to this, a 
coordinated campaign to highlight the potential that each and every trainee has to shape the next 
decade of radiotherapy research would surely be welcome. 
 
References 
1. Chalmers AJ, Chan C, Sebag-Montefiore D, Executive Group of the National Cancer Research 
Institute’s Clinical & Translational Radiotherapy Research Working Group. CTRad 10 Years On: 
From 10-point Plan to Top 10 Achievements. Clin Oncol (R Coll Radiol) 2020;32(1):9-12. 
2. Cancer Research UK. RadNet - our radiation research network. Available at: 
https://www.cancerresearchuk.org/funding-for-researchers/our-research-infrastructure/radnet-
our-radiation-research-network. Accessed 04/05/2020. 
3. The Royal College of Radiologists. Clinical oncology: UK workforce census 2018 report. London: 
The Royal College of Radiologists, 2019. 
4. Benstead K, Gilson D, Hanna L, Radhakrishna G, McAleer J, Bloomfield D et al. Training in clinical 
oncology: results of the Royal College of Radiologists’ survey of new consultants. Clin Oncol (R 
Col Radiol) 2012;24(10):e143-e148. 
5. Frazer R, Pugsley L, Button M, Cleves A. UK Training in Oncology: The View From ‘the Other Side’. 
Clin Oncol (R Col Radiol) 2019;31(4):209-211. 
6. Dickson J, Liu D, Bloomfield D. Training in Clinical Oncology and the Transition from Trainee to 
Consultant: Results of the Royal College of Radiologists’ 2015 Post-Certificate of Completion of 
Training Survey. Clin Oncol (R Coll Radiol) 2016;29(3):e64-e71. 
7. Goranov BB, Drew Y, Graham J, Iqbal MS, Kagzi M, Mahtab N et al. Academic Opportunities 
within Clinical Oncology Training. Clin Oncol (R Coll Radiol) 2013;25(7):446. 
8. Casswell G, Shakir R, Macnair A, O’Leary B, Smith F, Rulach R et al. UK Training in Clinical Oncology: 
The Trainees’ Viewpoint. Clin Oncol (R Coll Radiol) 2018;30(10):602-604. 
9. Faivre-Finn C. Breaking the Glass Ceiling for Women in Academic Clinical Oncology in the UK: A 
Personal View. Clin Oncol (R Coll Radiol) 2017;29(1):1-2. 
10. Vapiwala N, Moghanaki D, Movsas B. Cultivating Tomorrow’s Clinician Scientists: We Reap What 
We Sow. Int J Radiat Oncol Biol Phys 2015;92(2):206-210. 
11. Dietzel CT, Jablonska K, Niyazi M, Gauer T, Ebert N, Ostheimer C et al. Results from a 2016/2017 
survey performed by the working group “young DEGRO” of the German society of radiation 
oncology. Strahlenther Onkol 2018;194:293-302. 
12. Dahn MH, Best L, Bowes D. Attitudes towards research during residency training: a survey of 
Canadian radiation oncology residents and program directors. J Cancer Educ 2019 Jun 25. Doi: 
10.1007/s13187-019-10565-8. Epub ahead of print. 
13. Chang DT, Shaffer JL, Haffty BG, Wilson LD. Factors that determine academic versus private 
practice career interest in radiation oncology residents in the United States: Results of a 
nationwide survey. Int J Radiat Oncol Biol Phys 2013;87(3):464-470. 
14. Macknin JB, Brown A, Marcus Re. Does research participation make a difference in residency 
training? Clin Orthop Relat Res 2014;472:370-376. 
15. Reck SJ, Stratman EJ, Vogel C, Mukesh BN. Assessment of residents’ loss of interest in academic 
careers and identification of correctable factors. Arch Dermatol 2006;142:855-858. 
16. Takahashi O, Ohde S, Jacobs JL, Tokuda Y, Omata F, Fukui T. Residents’ experience of scholarly 
activities is associated with higher satisfaction with residency training. J Gen Intern Med 
2009;24(6):716-720. 
17. Gutovich JM, Den RB, Werner-Wasik M, Dicker AP, Lawrence YR. Predictors of Radiation 
Oncology Resident Research Productivity. J Am Coll Radiol 2013;10(3):185-9. 
18. Hong B, O’Sullivan ED, Henein C, Jones CM. Motivators and barriers to engagement with 
evidence-based practice among medical and dental trainees from the UK and Republic of 
Ireland: a national survey. BMJ Open 2019;9(10):e031809. 
19. Tharmalingam H, Vinayan A, Anyamene N. UK Training in Clinical Oncology: Tasters, Coasters & 
the National Recruitment Crisis. Clin Oncol (R Coll Radiol) 2018;30(10):599-601. 
20. The Royal College of Physicians Medical Workforce Unit. Focus on physicians: Census of 
consultant physicians and higher specialty trainees 2018. Available at: 
https://www.rcplondon.ac.uk/projects/outputs/focus-physicians-2018-19-census-uk-
consultants-and-higher-specialty-trainees. Accessed 04/05/2020. 
21. The Royal College of Radiologists. Summer Undergraduate Research Fellowships. Available at 
https://www.rcr.ac.uk/clinical-oncology/academic-oncology-and-research/summer-
undergraduate-research-fellowships. Accessed 04/05/2020. 
22. Chalmers A, Adams R, Bulbeck H, Burnet N, Evans P, Lambin P et al. Evaluating excellence in 
radiotherapy research: the UK CTRad ‘Centres of Excellence’ initiative.  Radiother Oncol 
2018;127(1):S910. 
23. National Cancer Research Institute Clinical and Translational Radiotherapy Research Working 
Group (CTRad) Proton Beam Clinical Trial Strategy Group. Proton Beam Therapy - the Challenges 
of Delivering High-quality Evidence of Clinical Benefit. Clin Oncol (R Coll Radiol) 2018;30(5):280-
284. 
24. Jones CM, Olsson-Brown A, Dobeson C, The Trainee Board of the National Oncology Trainees 
Collaborative for Healthcare Research. The National Oncology Trainees Collaborative for 
Healthcare Research. Clin Oncol (R Coll Radiol) 2020; epub ahead of print. 
25. National Institute for Health Research. Associate Principal Investigator Scheme. Available at 
https://www.nihr.ac.uk/documents/associate-principal-investigator-pi-
scheme/11694?diaryentryid=53625. Accessed 04/05/2020. 
26. Thiruthaneeswaran N, Turner S, Milross C, Gogna K. Promoting a research culture among junior 
radiation oncologists: outcomes from the introduction of the Australian and New Zealand 
research requirement in training. Clin Oncol (R Coll Radiol) 2014;26(3):162-173.  
27. Turner S, Sundaresan P, Mann K, Pryor D, Gebski V, Shaw T. Engaging future clinical oncology 
researchers: an initiative to integrate teaching of biostatistics and research methodology into 
specialty training. Clin Oncol (R Coll Radiol) 2016;28:306-316. 
28. Broke J, Milne E, Bezjak A, Millar BA, Giuliani M, Heeneman S. Mentorship needs for radiation 
oncology residents: implications for programme design. Clin Oncol (R Coll Radiol) 
2020;32(4):e119-e125. 
29. Noble K, Owens J, André F, Bakhoum SF, Loi S, Christian H et al. Securing the future of the 
clinician-scientist. Nat Cancer 2020;1:139-141. 
30. Thompson MK, Poortmans P, Chalmers AJ, Faivre-Finn C, Hall E, Huddart RA et al. Practice-
changing radiation therapy trials for the treatment of cancer: where are we 150 years after the 
birth of Marie Curie? Br J Cancer 2018;119(4):389-407. 
 
 
Figure 1: A roadmap illustrating practical steps to nurture research active trainees, by stage of 
training. AFP: Academic Foundation Programme; NHS: National Health Service; NIHR: National 
Institute for Health Research; OOP: Out-of-Programme; PI: Principal Investigator; RCR: Royal College 
of Radiologists; ST: Specialty Training.
 
 
Figure 2: A representation of research areas relevant to clinical oncology. 
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